Data on monoclonal antibodies described by researchers at University of Thessaloniki, Department of Gastroenterology

Current study results from the report, "Efficacy and safety of infliximab in steroid-dependent ulcerative colitis patients," have been published. "Limited data exist concerning infliximab administration in steroid-dependent ulcerative colitis (UC) patients. The aim of this study was to evaluate the efficacy and safety of infliximab in steroid-dependent disease. Sixteen corticosteroid-dependent patients who received infusions of infliximab (5 mg/kg) at 0, 2 and 6 weeks and thereafter every 8 weeks (Group A), were compared with eight patients treated with methylprednisolone (0.8-1 mg/kg body weight) daily for three weeks followed by a tapering regimen up to the minimal dose to maintain a...

Want to see the full article?

• Purchase this article for only $3.00